Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Department of Pediatric Newborn Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Crit Care Med. 2020 May;48(5):e409-e417. doi: 10.1097/CCM.0000000000004244.
Sepsis results in organ dysfunction caused by a dysregulated host response, in part related to the immune response of a severe infection. Mesenchymal stromal cells are known to modulate the immune response, and expression of stromal cell-derived factor-1 regulates mobilization of neutrophils from the bone marrow. We are investigating the importance of stromal cell-derived factor-1 in mesenchymal stromal cells and its role in promoting neutrophil function after the onset of cecal ligation and puncture-induced sepsis. Stromal cell-derived factor-1 expression was silenced in mesenchymal stromal cells, compared with the control scrambled construct mesenchymal stromal cells.
Animal study and cell culture.
Laboratory investigation.
BALB/c mice.
Polymicrobial sepsis was induced by cecal ligation and puncture. shSCR mesenchymal stromal cells and shSDF-1 mesenchymal stromal cells were delivered by tail vein injections to septic mice. The mice were assessed for survival, bacterial clearance, and the inflammatory response during sepsis in each of the groups. Mesenchymal stromal cells were also assessed for their ability to promote bacterial phagocytosis by neutrophils.
Injection of shSCR mesenchymal stromal cells after the onset of sepsis led to an increase in mouse survival (70%) at 7 days, whereas survival of mice receiving shSDF-1 mesenchymal stromal cells was significantly diminished (33%). The loss of survival benefit in mice receiving shSDF-1 mesenchymal stromal cells was associated with less efficient bacterial clearance compared with shSCR mesenchymal stromal cells. Although shSCR mesenchymal stromal cells, or their conditioned medium, were able to increase neutrophil phagocytosis of bacteria, this effect was significantly blunted with shSDF-1 mesenchymal stromal cells. Assessment of peritoneal inflammation revealed that neutrophils were significantly increased and more immature in septic mice receiving shSDF-1 mesenchymal stromal cells. This response was associated with hypocellularity and increased neutrophil death in the bone marrow of mice receiving shSDF-1 mesenchymal stromal cells.
Expression of stromal cell-derived factor-1 in mesenchymal stromal cells enhances neutrophil function with increased phagocytosis, more efficient clearance of bacteria, and bone marrow protection from depletion of cellular reserves during sepsis.
脓毒症导致器官功能障碍,这是宿主反应失调的结果,部分与严重感染的免疫反应有关。间充质基质细胞可调节免疫反应,基质细胞衍生因子-1 的表达可调节中性粒细胞从骨髓中的动员。我们正在研究基质细胞衍生因子-1 在间充质基质细胞中的重要性及其在盲肠结扎和穿刺诱导脓毒症发生后促进中性粒细胞功能的作用。与对照 scrambled 构建体间充质基质细胞相比,基质细胞衍生因子-1 的表达在间充质基质细胞中被沉默。
动物研究和细胞培养。
实验室研究。
BALB/c 小鼠。
盲肠结扎和穿刺诱导多微生物脓毒症。尾静脉注射 shSCR 间充质基质细胞和 shSDF-1 间充质基质细胞至脓毒症小鼠。评估各组小鼠在脓毒症期间的存活、细菌清除和炎症反应。还评估了间充质基质细胞促进中性粒细胞吞噬细菌的能力。
脓毒症发生后注射 shSCR 间充质基质细胞可提高小鼠 7 天的存活率(70%),而注射 shSDF-1 间充质基质细胞的小鼠存活率明显降低(33%)。与 shSCR 间充质基质细胞相比,接受 shSDF-1 间充质基质细胞的小鼠存活获益的丧失与细菌清除效率较低相关。尽管 shSCR 间充质基质细胞或其条件培养基能够增加中性粒细胞对细菌的吞噬作用,但这种作用在接受 shSDF-1 间充质基质细胞的小鼠中明显减弱。评估腹膜炎症发现,接受 shSDF-1 间充质基质细胞的脓毒症小鼠中中性粒细胞明显增加且更不成熟。这种反应与骨髓中细胞储备减少相关,导致骨髓中细胞减少和中性粒细胞死亡增加。
间充质基质细胞中基质细胞衍生因子-1 的表达增强了中性粒细胞的功能,增加了吞噬作用,更有效地清除细菌,并保护骨髓免受脓毒症期间细胞储备的消耗。